Deep Candida
albicans infection is one of the
major causes of death in immunosuppressed hosts. Remodeling macrophages
to phenotype M1 can decrease fungus burden and facilitate combating C. albicans under an immunosuppressive state. In this study,
a nanotrinity was exploited to direct fungicidal macrophage polarization
by leveraging the regulation pathways in macrophage redifferentiation.
Conventional chemotherapeutic imatinib, which can abrogate M2 macrophage
polarization via “shutting off” the
STAT6 phosphorylation pathway, was encapsulated in biodegradable polymeric
nanoparticles. In house-customized dual functional mannosylated chitosan
oligosaccharides were then coated on the surface of the imatinib-laden
nanoparticles, and thus, a mannosylated nanotrinity was achieved with
ternary functions for macrophage remodeling: (i) imatinib-blocked
STAT6 phosphorylation pathway for decreasing M2 macrophage population;
(ii) chitosan oligosaccharides-mediated TLR-4 pathway activation that
could promote macrophage redifferentiation to M1 phenotype; (iii)
mannose motif-enhanced macrophage targeting. After physiochemical
characterization, regulatory effects of the mannosylated nanotrinity
on macrophages and the anti-C. albicans efficacy
were evaluated at the cellular level and animal level, respectively.
The results demonstrated that our mannosylated nanotrinity could efficiently
induce macrophage polarization toward the M1 phenotype, decrease M2
phenotype production, and markedly lessen fungus burden and increased
the median survival time of mice infected with C. albicans. Therefore, the mannosylated nanotrinity developed in this study
could significantly induce macrophage remodeling in situ by the two-pronged process, “turning on” M1 phenotype
polarization meanwhile “shutting off” M2 phenotype polarization,
and thus allowed to eradicate C. albicans infection.